Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
Bioinformatics ; 25(1): 128-9, 2009 Jan 01.
Article in English | MEDLINE | ID: mdl-19015129

ABSTRACT

UNLABELLED: Oligonucleotide microarray probes are designed to match specific transcripts present in databases that are regularly updated. As a consequence probes should be checked every new database release. We thus developed an informatics tool allowing the semi-automatic update of probe collections of long oligonucleotides and applied it to the mouse RefSeq database. AVAILABILITY: http://www.bio.espci.fr/sol/


Subject(s)
Algorithms , Automation , Computational Biology/methods , Genome/genetics , Oligonucleotide Array Sequence Analysis , Oligonucleotides/genetics , Databases, Nucleic Acid , User-Computer Interface
2.
J Cell Sci ; 114(Pt 19): 3517-27, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11682611

ABSTRACT

The dopamine D(2) receptor exists as a long (D(2a)) and a short (D(2b)) isoform generated by alternative splicing of the corresponding transcript, which modifies the length of the third cytoplasmic loop implicated in heterotrimeric G-protein-coupling. Anatomical data suggested that this segment regulates the intracellular traffic and localization of the receptor. To directly address this question we used a combination of tagging procedures and immunocytochemical techniques to detect each of the two D(2) receptor isoforms. Surprisingly, most of the newly synthesized receptors accumulate in large intracellular compartments, the plasma membrane being only weakly labeled, without significant difference between the two receptor isoforms. Double labeling experiments showed that this localization corresponded neither to endosomal compartments nor to the Golgi apparatus. The D(2) receptor is mostly retained in the endoplasmic reticulum (ER), the long isoform more efficiently than the short one. It is accompanied by a striking vacuolization of the ER, roughly proportional to the expression levels of the two receptor isoforms. This phenomenon is partly overcome by treatment with pertussis toxin. In addition, an intrinsic activity of the D(2) receptor isoforms is revealed by [(35)S]-GTP gamma S binding and cAMP assay, which suggested that expression of weakly but constitutively active D(2) receptors promotes activation of heterotrimeric G protein inside the secretory pathway. This mechanism may participate in the regulation of the cellular traffic of the D(2) receptors isoforms.


Subject(s)
Endoplasmic Reticulum/metabolism , Receptors, Dopamine D2/metabolism , Animals , COS Cells , Cell Compartmentation/physiology , Cell Membrane/metabolism , Epitopes , Gene Expression/physiology , Glioma , HeLa Cells , Heterotrimeric GTP-Binding Proteins/metabolism , Humans , Isomerism , Kidney/cytology , Receptors, Dopamine D2/chemistry , Receptors, Dopamine D2/genetics , Transfection , Vacuoles/metabolism
3.
J Soc Biol ; 194(2): 87-93, 2000.
Article in French | MEDLINE | ID: mdl-11098433

ABSTRACT

Dopamine is a widespread neurotransmitter which exerts numerous neuromodulatory actions in the vertebrate central nervous system. This pleiotropic activity relies on the organisation of dopamine-synthesizing neuronal pathways and on a multiplicity of specific membrane receptors. A comparative approach has been undertaken to gain clues on the genetic events which took place during evolution to devise the dopamine systems of modern vertebrates. The localisation and phenotype of dopamine-synthesizing neurones is determined by different gene networks in each of the dopaminergic nuclei. However, despite this amazing diversity, the overall organisation of the dopaminergic nuclei is strinkingly conserved in the main vertebrates groups. In sharp contrast, the number of dopamine receptors subtypes has been multiplied by two major steps of gene duplications during vertebrates evolution. The first one occurred in the lineage leading to agnathans, whereas the second was concomitant to the emergence of cartilaginous fish. Accordingly, three subtypes exist in D1 receptor class (D1A, D1B, D1C) in all the jawed vertebrates, with two exceptions: eutherian mammals where only two D1 subtypes are found (D1A, D1B) and archosaurs where a fourth subtype is present (D1D). Comparisons of the pharmacological and biochemical characteristics of the dopamine receptors in vertebrate groups revealed homologous features that define each of the receptor subtypes and that have been fixed after gene duplications. The comparison of the distribution of the D1 receptor transcripts in the brain of teleosts and mammals points to significant conserved or derived expression territories, revealing previously neglected aspects of dopamine physiology in vertebrates.


Subject(s)
Dopamine/physiology , Evolution, Molecular , Vertebrates/metabolism , Animals , Brain/ultrastructure , Brain Chemistry , Dopamine/biosynthesis , Fishes/anatomy & histology , Fishes/genetics , Fishes/metabolism , Gene Duplication , Mammals/anatomy & histology , Mammals/genetics , Mammals/metabolism , Models, Neurological , Neural Pathways/metabolism , Neural Pathways/ultrastructure , Neurons/classification , Neurons/metabolism , Phylogeny , Receptors, Dopamine D1/classification , Receptors, Dopamine D1/genetics , Receptors, Dopamine D1/physiology , Reptiles/genetics , Species Specificity , Vertebrates/anatomy & histology , Vertebrates/genetics
4.
Proc Natl Acad Sci U S A ; 97(15): 8606-11, 2000 Jul 18.
Article in English | MEDLINE | ID: mdl-10890919

ABSTRACT

The possible molecular basis for the previously described antagonistic interactions between adenosine A(1) receptors (A(1)R) and dopamine D(1) receptors (D(1)R) in the brain have been studied in mouse fibroblast Ltk(-) cells cotransfected with human A(1)R and D(1)R cDNAs or with human A(1)R and dopamine D(2) receptor (long-form) (D(2)R) cDNAs and in cortical neurons in culture. A(1)R and D(1)R, but not A(1)R and D(2)R, were found to coimmunoprecipitate in cotransfected fibroblasts. This selective A(1)R/D(1)R heteromerization disappeared after pretreatment with the D(1)R agonist, but not after combined pretreatment with D(1)R and A(1)R agonists. A high degree of A(1)R and D(1)R colocalization, demonstrated in double immunofluorescence experiments with confocal laser microscopy, was found in both cotransfected fibroblast cells and cortical neurons in culture. On the other hand, a low degree of A(1)R and D(2)R colocalization was observed in cotransfected fibroblasts. Pretreatment with the A(1)R agonist caused coclustering (coaggregation) of A(1)R and D(1)R, which was blocked by combined pretreatment with the D(1)R and A(1)R agonists in both fibroblast cells and in cortical neurons in culture. Combined pretreatment with D(1)R and A(1)R agonists, but not with either one alone, substantially reduced the D(1)R agonist-induced accumulation of cAMP. The A(1)R/D(1)R heteromerization may be one molecular basis for the demonstrated antagonistic modulation of A(1)R of D(1)R receptor signaling in the brain. The persistence of A(1)R/D(1)R heteromerization seems to be essential for the blockade of A(1)R agonist-induced A(1)R/D(1)R coclustering and for the desensitization of the D(1)R agonist-induced cAMP accumulation seen on combined pretreatment with D(1)R and A(1)R agonists, which indicates a potential role of A(1)R/D(1)R heteromers also in desensitization mechanisms and receptor trafficking.


Subject(s)
Receptors, Dopamine D1/metabolism , Receptors, Purinergic P1/metabolism , 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine/pharmacology , Adenosine/analogs & derivatives , Adenosine/pharmacology , Animals , Cell Line , Cells, Cultured , Cerebral Cortex/cytology , Cyclic AMP/metabolism , Dimerization , Dopamine Agonists/pharmacology , Fibroblasts/cytology , Fibroblasts/drug effects , Fibroblasts/metabolism , Humans , Mice , Neurons/cytology , Neurons/drug effects , Neurons/metabolism , Precipitin Tests , Rats , Rats, Sprague-Dawley , Receptors, Dopamine D1/genetics , Receptors, Dopamine D1/physiology , Receptors, Dopamine D2/metabolism , Receptors, Purinergic P1/genetics , Receptors, Purinergic P1/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...